Edo Kaluski, MD
Interventional Cardiology · Sayre, PANPI 1245321249
Payments from drug & device makers
Across 582 payments — averaging $424.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$194K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$23K
- Amgen$17K
- Vifor (international) Ltd.$2K
- Novartis$1K
- AstraZeneca$1K
- plus $8K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 46 | $194,313 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $22,963 |
| Amgen | 43 | $16,827 |
| Vifor (international) Ltd. | 1 | $2,080 |
| Novartis | 82 | $1,290 |
| AstraZeneca | 39 | $1,206 |
| Pfizer | 69 | $1,022 |
| Medtronic(2 entities) | 42 | $992 |
| Boston Scientific | 13 | $903 |
| Johnson & Johnson | 45 | $717 |
| Medicure Pharma Inc. | 2 | $640 |
| Boehringer Ingelheim | 32 | $556 |
| Actelion Pharmaceuticals US, Inc. | 23 | $491 |
| Abiomed | 8 | $364 |
| Abbott | 18 | $351 |
| Amarin Pharma, Inc. | 18 | $329 |
| Inari Medical, Inc. | 6 | $261 |
| Biotronik Inc. | 15 | $257 |
| E.r. Squibb & Sons, L.L.C. | 10 | $231 |
| Novo Nordisk | 10 | $183 |
| Philips North America LLC | 2 | $166 |
| Stryker | 2 | $163 |
| Chiesi USA, Inc. | 6 | $126 |
| Bridgebio Pharma, Inc. | 6 | $116 |
| Scpharmaceuticals Inc. | 6 | $110 |
| Lexicon Pharmaceuticals, Inc. | 3 | $58 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| Cardiovascular Systems Inc. | 3 | $25 |
| Edwards Lifesciences | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Bayer | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $13 |
How this compares
$246,906 in reported general payments places this provider in the 85th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Sayre
- William GrayWynnewood$3.3M
- Eric GnallWynnewood$2.4M
- Howard HerrmannPhiladelphia$2.2M
- Ramzi KhalilPittsburgh$1.6M
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1.3M
- David LasordaPittsburgh$1.1M
- Nainesh PatelAllentown$1.1M
- Jay GiriPhiladelphia$1M
- James HarveyChambersburg$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.